PMDIX
Price
$20.33
Change
-$0.12 (-0.59%)
Updated
Nov 13 closing price
VMVIX
Price
$67.47
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

PMDIX vs VMVIX

Header iconPMDIX vs VMVIX Comparison
Open Charts PMDIX vs VMVIXBanner chart's image
Principal Small-MidCap Dividend Inc Inst
Price$20.33
Change-$0.12 (-0.59%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Investor
Price$67.47
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
PMDIX vs VMVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PMDIX vs. VMVIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMDIX is a Buy and VMVIX is a Buy.

FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.9B vs. PMDIX (1.82B). VMVIX pays higher dividends than PMDIX: VMVIX (2.03) vs PMDIX (1.43). PMDIX was incepted earlier than VMVIX: PMDIX (13 years) vs VMVIX (18 years). PMDIX is a more actively managed with annual turnover of: 26.50 vs. VMVIX (22.00). PMDIX has a lower initial minimum investment than VMVIX: PMDIX (0) vs VMVIX (3000). PMDIX annual gain was more profitable for investors over the last year : 35.91 vs. VMVIX (28.28). VMVIX return over 5 years is better than : 48.79 vs. PMDIX (44.99).
PMDIXVMVIXPMDIX / VMVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years18 years-
Gain YTD18.33518.43899%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.82B30.9B6%
Annual Yield % from dividends1.432.0371%
Returns for 1 year35.9128.28127%
Returns for 3 years15.2014.93102%
Returns for 5 years44.9948.7992%
Returns for 10 years72.47100.4572%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRPH0.770.03
+4.39%
ProPhase Labs
U19.13-0.09
-0.47%
Unity Software
WAFD37.15-0.28
-0.75%
WaFd
TCRT2.40-0.04
-1.64%
Alaunos Therapeutics Inc.
ATRO16.49-0.38
-2.25%
Astronics Corp